Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy

被引:13
作者
Patel, V
Hedayati, SS
机构
[1] Vet Affairs N Texas Healthcare Syst, Div Nephrol, Dept Med, Dallas, TX 75216 USA
[2] Univ Texas, SW Med Ctr, Div Nephrol, Dept Med, Dallas, TX 75230 USA
来源
NATURE CLINICAL PRACTICE NEPHROLOGY | 2006年 / 2卷 / 02期
关键词
highly active antiretroviral therapy; HIV; lactic acidosis; nucleoside reverse transcriptase inhibitor;
D O I
10.1038/ncpneph0102
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background A 51-year-old man with HIV infection on highly active antiretroviral therapy presented with abdominal pain and exertional dyspnea. Physical examination revealed increased respiration and cachexia. Laboratory tests showed a lactic acid concentration elevated to 6.4 mM. Investigation Physical examination, blood chemistry, arterial blood gas, urine analysis, chest X-ray, and ultrasound of liver. Diagnosis Nucleoside reverse transcriptase inhibitor (NRTI)-induced lactic acidosis, hepatitis and chemical pancreatitis. Proximal renal tubular acidosis with Fanconi's syndrome, secondary to treatment with tenofovir. Management The patient was supported on intravenous and oral bicarbonate, riboflavin and phosphorus supplementation. Highly active antiretroviral therapy was discontinued. The patient's lactate level decreased about 2 weeks after discharge.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 16 条
[1]   Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors:: A case-control study [J].
Bonnet, F ;
Bonarek, M ;
Morlat, P ;
Mercié, P ;
Dupon, M ;
Gemain, MC ;
Malvy, D ;
Bernard, N ;
Pellegrin, JL ;
Beylot, J .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (10) :1324-1328
[2]   Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [J].
Brinkman, K ;
Smeitink, JA ;
Romijn, JA ;
Reiss, P .
LANCET, 1999, 354 (9184) :1112-1115
[3]   Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis - role of haemodialysis treatment [J].
Chodock, R ;
Mylonakis, E ;
Shemin, D ;
Runarsdottir, V ;
Yodice, P ;
Renzi, R ;
Tashima, K ;
Towe, C ;
Rich, JD .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (10) :2484-2486
[4]   Bench-to-bedside review: Severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors [J].
Claessens, YE ;
Chiche, JD ;
Mira, JP ;
Cariou, A .
CRITICAL CARE, 2003, 7 (03) :226-232
[5]   Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine [J].
Claessens, YE ;
Cariou, A ;
Monchi, M ;
Soufir, L ;
Azoulay, E ;
Rouges, P ;
Goldgran-Toledano, D ;
Branche, F ;
Dhainaut, JF .
CRITICAL CARE MEDICINE, 2003, 31 (04) :1042-1047
[6]   Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients [J].
Coté, HCF ;
Brumme, ZL ;
Craib, KJP ;
Alexander, CS ;
Wynhoven, B ;
Ting, LL ;
Wong, H ;
Harris, M ;
Harrigan, PR ;
O'Shaughnessy, MV ;
Montaner, JSG .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11) :811-820
[7]   Fanconi's syndrome in HIV+ adults:: Report of three cases and literature review [J].
Earle, KE ;
Seneviratne, T ;
Shaker, J ;
Shoback, D .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (05) :714-721
[8]   Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients:: Report of 12 cases and review of the literature [J].
Falcó, V ;
Rodríguez, D ;
Ribera, E ;
Martínez, E ;
Miró, JM ;
Domingo, P ;
Diazaraque, R ;
Arribas, JR ;
González-García, JJ ;
Montero, F ;
Sánchez, L ;
Pahissa, A .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :838-846
[9]  
FORTGANG IS, 1995, AM J GASTROENTEROL, V90, P1433
[10]  
Hocqueloux L, 2003, HIV Med, V4, P18, DOI 10.1046/j.1468-1293.2003.00132.x